
Hershey and other chocolate makers hike prices as cocoa remains near record highs
But here's the bad news: Hershey and other chocolate makers are continuing to hike prices, saying a volatile cocoa market gives them no choice.
Hershey, the maker of Reese's, Whoppers, barkThins and other chocolate candies, said Wednesday that it will be raising U.S. retail prices later this fall. In some cases, pack sizes will get smaller; in others, list prices will rise. The average price increase will be in the low double-digit percentages.
'This change is not related to tariffs or trade policies. It reflects the reality of rising ingredient costs including the unprecedented cost of cocoa,' Hershey said in a statement.
Hershey stressed that the price increases won't apply to products specially packaged for Halloween.
On Tuesday, Swiss chocolatier Lindt said it raised prices by 15.8% in the first half of this year. The company said it was able to offset some of the higher cost of cocoa with long-term contracts but had to pass much of it on to consumers.
'The development of the global chocolate market in the first half of 2025 was a continuation of what we saw in 2024, with cocoa prices remaining close to record highs,' said Adalbert Lechner, Lindt's CEO, in a conference call with investors.
Cloetta, a Swedish confectionary company, told investors last week that it raised chocolate prices in the second quarter. And Nestle raised U.S. prices for products like Toll House chocolate chips in the spring.
Cocoa prices have more than doubled over the past two years due to poor weather and disease in West Africa, which supplies more than 70% of the world's cocoa.
Cocoa futures, which are binding contracts for a specific quantity of cocoa, stood at $7,380 per metric ton on Wednesday, according to the International Cocoa Organization, which releases a daily average of prices in London and New York.
That's down from December's peak of $11,984, but it's still 121% higher than two years ago.
And the situation remains volatile. According to the International Cocoa Organization, prices surged in early June on concerns about production in Ivory Coast but eased on optimistic forecasts for production in Ghana and Latin America. They rose again in late June after heavy rains in West Africa, which could worsen the outbreak of diseases that harm crops.
'It's almost a bit dangerous to comment on this because it's changing so fast,' Cloetta Chief Financial Officer Frans Ryden said last week in a conference call with investors. 'This is something that's moving hugely up and down all the time.'
Meanwhile, prices have been rising on store shelves. The average unit price of a chocolate bar in the U.S. in July 2021 was $2.43, according to Nielsen IQ, a market research company. As of last week, it was $3.45, a 41% increase.
That's hurting customer demand. Nielsen said unit sales of chocolate fell 1.2% in the year ending July 12.
Tariffs could also impact U.S. prices. President Donald Trump threatened a 21% tariff on cocoa and other products from Ivory Coast in April, for example, but then paused the tariffs' implementation.
The National Confectioners Association is asking the Trump administration to protect cocoa from tariffs. The group says the U.S. imports nearly $4.4 billion in chocolate, cocoa and candies each year, and the association's members export nearly $2 billion in American-made chocolates and candy annually.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a few seconds ago
- Yahoo
Alcon strikes $1.5bn deal to acquire ailing rival STAAR Surgical
Alcon has agreed to acquire struggling rival eyecare specialist STAAR Surgical in an equity deal valued at around $1.5bn. The deal equates to the buyout of STAAR's outstanding stock at $28 per share and will avail Alcon of STAAR's EVO Implantable Collamer Lens (ICL) portfolio. STAAR's EVO ICLs address vision correction for conditions including myopia with and without astigmatism via a minimally invasive, reversible procedure that does not remove corneal tissue. Research estimates that 500 million individuals globally are currently considered 'high myopes', with 50% of the global population projected to be myopic to some extent by 2050. Alcon said the addition of STAAR's EVO ICL will complement its laser vision correction business and positively impact profit margins from year two post-transaction. The deal is expected to close within six to 12 months, pending customary closing conditions. Alcon CEO David Endicott commented: 'With the number of high myopes rising globally, the acquisition of STAAR enhances our ability to offer a leading surgical vision correction solution for those who are not ideal candidates for other refractive surgeries such as LASIK. 'This transaction will allow us to provide treatment options across the full spectrum of myopia – from contact lenses to surgical interventions – reinforcing our commitment to addressing the most significant needs in eye care.' Alcon's acquisitive streak and the culmination of STAAR's market challenges The STAAR buyout marks the latest deal in what has been an acquisitive year for Alcon. In March, the Swiss-headquartered company acquired Lensar in a deal valued at around $356m, gaining access to Lensar's ALLY robotic cataract laser treatment system, which Alcon expects to enhance the capabilities of its femtosecond laser-assisted cataract surgery (FLACS) technology. Last month, Alcon announced plans to acquire LumiThera in a deal set to give it control of the US-based company's photobiomodulation device for treating early and intermediate dry age-related macular degeneration (AMD). For STAAR, the Alcon acquisition puts a stopper on a challenging period for the company. STAAR's Q1 2025 financials revealed a 45% decline in sales to $42.6m, down from $77.4m in Q1 2024. The California-based company chiefly attributed the decline to weakened demand in China and additional headwinds due to Chinese Government initiatives affecting device procurement. To steady the ship, STAAR revealed plans for a $30m share buyback programme in May to account for volatility in the global macroeconomic environment. Commenting on the Alcon acquisition, STAAR CEO Stephen Farrell acknowledged that China headwinds had significantly impacted its viability as a standalone company. Farrell said: 'We believe the transaction with Alcon represents the best path forward and provides the greatest value for STAAR shareholders.' STAAR's view on the Chinese procurement market is likely about the country's procurement practices for foreign entities. In June, the European Union (EU) voted to ban Chinese companies from participating in public procurement tenders in the bloc's medical device sector for contracts valued over €5m ($5.72m) after an EU investigation found that fair access to foreign companies for public tenders in China was not reciprocated. "Alcon strikes $1.5bn deal to acquire ailing rival STAAR Surgical" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


CNBC
3 minutes ago
- CNBC
"Everyone can be a developer of software," says Lovable CEO
Anton Osika, CEO at Swedish unicorn Lovable on his company's recent funding round, their profitability outlook and the impact AI will have on the jobs market.


CNBC
2 hours ago
- CNBC
Dollar edges up vs euro and yen, but still close to Friday's lows
The dollar edged up against the euro and the yen, but remained within striking distance of Friday's lows, after weak U.S. jobs data boosted bets on Federal Reserve rate cuts and triggered a sharp selloff in the greenback. Goldman Sachs expects the Federal Reserve to deliver three consecutive 25 basis-point rate cuts starting in September, with a 50 basis-point move possible if the next jobs report shows a further rise in unemployment. It also sees the European Central Bank as having concluded its easing cycle. Economists raised their growth forecasts for the euro area and Japan following relatively benign trade agreements, while arguing that Friday's U.S. jobs report confirmed the economy is hovering near stall speed. Meanwhile the firing of the head of the Bureau of Labor Statistics (BLS) on Friday, and the resignation of Fed Governor Adriana Kugler, could harden the views of the FOMC to ensure its independence is protected, analysts said, recalling that the new appointee will be just one vote on the Fed's Federal Open Market Committee (FOMC). The euro was last down 0.12% at $1.15592, after hitting on Friday $1.15855. The dollar index, which measures the U.S. currency against six counterparts, was at 98.816, after touching a one-week low earlier in the session at 98.609. "Traders likely inferred that the (U.S. jobs) report gave President Donald Trump even more justification to 'fire' Jay Powell," said Thierry Wizman, global forex and rates strategist at Macquarie Group. "Alternatively, it gave Trump even more support for giving the Chairmanship to someone that would be more 'structurally' dovish," he added, arguing that Friday's employment report shifted the outlook for where the Fed Funds rate target will be one year from now. Money markets are now pricing in a 92% chance of the Fed cutting rates in its next meeting in September, compared with 63% a week earlier. They also indicate 130 bps of rate cuts by October 2026, 30 bps more than the levels seen on Friday before U.S. jobs data. The Japanese yen was down 0.14% at 147.3 per dollar after minutes of its June policy meeting showed a few Bank of Japan board members said the central bank would consider resuming interest rate increases if trade frictions de-escalate. The focus remains on tariff uncertainties, after the latest duties imposed on imports from scores of countries last week by Trump stoked worries about the health of the global economy. The Swiss franc extended losses for a second day, weakening 0.1% to 0.8089 per dollar after dropping 0.5% in the previous session. However it was still above the levels seen before Friday's economic figures, at around 0.8128. Switzerland is looking to make a "more attractive offer" in trade talks with Washington, to avert a 39% U.S. import tariff on Swiss goods that threatens its export-driven economy. In other currencies, the Australian dollar eased 0.05% to $0.6464, while the New Zealand dollar slipped 0.1% to $0.5898.